Calidi Biotherapeutics logo

Calidi Biotherapeutics Share Price (NYSE: CLDI)

$1.64

-0.07

(-4.09%)

Last updated on

Check the interactive Calidi Biotherapeutics Stock chart to analyse performance

Calidi Biotherapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.62
    Today's High:$1.72

    Day's Volatility :5.81%

  • 52 Weeks Low:$1.54
    52 Weeks High:$46.68

    52 Weeks Volatility :96.7%

Calidi Biotherapeutics Stock Returns

PeriodCalidi Biotherapeutics IncIndex (Russel 2000)
3 Months
-60.5%
0.0%
6 Months
-81.53%
0.0%
1 Year
-88.01%
0.0%
3 Years
-99.72%
-4.7%

Calidi Biotherapeutics Inc Key Stats

Check Calidi Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.71
Open
$1.72
Today's High
$1.72
Today's Low
$1.62
Market Capitalization
$9.1M
Today's Volume
$304.7K
52 Week High
$46.68
52 Week Low
$1.54
Revenue TTM
$0.0
EBITDA
$-19.5M
Earnings Per Share (EPS)
$-0.2
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Calidi Biotherapeutics Stock including INR - Dollar returns

The Calidi Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Calidi Biotherapeutics investment value today

Current value as on today

₹17,272

Returns

₹82,728

(-82.73%)

Returns from Calidi Biotherapeutics Stock

₹88,012 (-88.01%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Calidi Biotherapeutics Stock

-77.92%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Investment in Calidi Biotherapeutics Shares from India has dropped by -77.92% over the past 30 days, indicating reduced transactional activity.

-76%

Period: Jul 30, 2025 to Aug 29, 2025. Change in 30 Days versus previous period

Search interest for Calidi Biotherapeutics Stock from India on INDmoney has decreased by -76% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Calidi Biotherapeutics Stock

Rating
Trend

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Calidi Biotherapeutics(by analysts ranked 0 to 5 stars)

Calidi Biotherapeutics Share Price Target

What analysts predicted

Upside of 7217.37%

Target:

$120.00

Current:

$1.64

Calidi Biotherapeutics share price target is $120.00, a slight Upside of 7217.37% compared to current price of $1.64 as per analysts' prediction.

Calidi Biotherapeutics Stock Insights

  • Price Movement

    In the last 1 month, CLDI stock has moved down by -76.6%
  • CLDI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 157.9%

Calidi Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Calidi Biotherapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Calidi Biotherapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Calidi Biotherapeutics Inc logo
-77.06%
-81.53%
-88.01%
-99.72%
-99.72%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.98%
-0.05%
-6.32%
Beone Medicines Ltd logo
1.77%
24.81%
59.79%
78.52%
26.86%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-21.18%
38.72%
40.03%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
69.91%
115.96%
236.5%

About Calidi Biotherapeutics Inc

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, develops allogeneic stem cell-based and enveloped virus platforms to potentiate and deliver oncolytic viruses in the United States. Its product pipeline comprises CLD-101, which is in Phase 1b/2 clinical trial for the treatment of high-grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck squamous cell carcinoma, and soft tissue sarcoma, which is in pre-clinical studies; CLD-301 for multiple indications, which is in preclinical studies; and CLD-400 for certain lung cancer and metastatic solid tumors. The company also offers oncolytic virus platforms, such as NeuroNova, SuperNova, and RTNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Organization
Calidi Biotherapeutics
Employees
28
CEO
Dr. Eric E. Poma Ph.D.
Industry
Miscellaneous

Key Management of Calidi Biotherapeutics Inc

NameTitle
Mr. Andrew C. Jackson
Chief Financial Officer
Ms. Wendy Pizarro Campbell Esq.
Chief Legal, Chief Corporate Dev, Chief Diversity & Corp Sec.
Dr. Eric E. Poma Ph.D.
CEO & Director
Dr. Antonio Fernandez Santidrian Ph.D., Pharm.D.
Head of Technical Operations & Chief Scientific Officer
Dr. Guy Travis Clifton M.D.
Chief Medical Officer, Consultant & Advisor

Important FAQs about investing in CLDI Stock from India :

What is Calidi Biotherapeutics share price today?

Calidi Biotherapeutics share price today is $1.64 as on at the close of the market. Calidi Biotherapeutics share today touched a day high of $1.72 and a low of $1.62.

What is the 52 week high and 52 week low for Calidi Biotherapeutics share?

Calidi Biotherapeutics share touched a 52 week high of $46.68 and a 52 week low of $1.54. Calidi Biotherapeutics stock price today i.e. is closed at $1.64, lower by 96.49% versus the 52 week high.

How to invest in Calidi Biotherapeutics Stock (CLDI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Calidi Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Calidi Biotherapeutics Shares that will get you 0.9146 shares as per Calidi Biotherapeutics share price of $1.64 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Calidi Biotherapeutics Stock (CLDI) from India?

Indian investors can start investing in Calidi Biotherapeutics (CLDI) shares with as little as ₹88.286 or $1 (as of August 30, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Calidi Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 30, 2025). Based on Calidi Biotherapeutics share’s latest price of $1.64 as on August 30, 2025 at 1:29 am IST, you will get 6.0976 shares of Calidi Biotherapeutics. Learn more about fractional shares .

What are the returns that Calidi Biotherapeutics has given to Indian investors in the last 5 years?

Calidi Biotherapeutics stock has given -99.72% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?